IMMUNE-RELATED ADVERSE EVENT
Clinical trials for IMMUNE-RELATED ADVERSE EVENT explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-RELATED ADVERSE EVENT trials appear
Sign up with your email to follow new studies for IMMUNE-RELATED ADVERSE EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Asthma drug could tame Immunotherapy's lung side effects
Disease control Recruiting nowThis study tests whether a daily inhaled steroid (budesonide), commonly used for asthma, can prevent lung inflammation from coming back in cancer patients who had a severe immune reaction to immunotherapy. About 94 adults with solid tumors who recently recovered from checkpoint i…
Matched conditions: IMMUNE-RELATED ADVERSE EVENT
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New hope for cancer patients: drug may cut steroid need for treatment-related arthritis
Symptom relief Recruiting nowThis study tests if the arthritis drug adalimumab can help people with joint pain caused by cancer immunotherapy. About 30 adults will get either adalimumab or standard steroid treatment. The goal is to see if adalimumab reduces the need for steroids and their side effects.
Matched conditions: IMMUNE-RELATED ADVERSE EVENT
Phase: PHASE2 • Sponsor: Tom Appleton • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC